You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
德琪醫藥-B(06996.HK)上半年期內虧損收窄至7640萬元

格隆匯8月22日丨德琪醫藥-B(06996.HK)公佈中期業績,截至2025年6月30日止六個月,收入由從截至2024年6月30日止六個月的人民幣6080萬元減少人民幣760萬元至人民幣5320萬元。於2023年12月,希維奧®(塞利尼索)成功獲納入2023年版國家醫保目錄,由於積極的市場預期,初始推動了截至2024年6月30日止六個月的強勁市場增長。隨後,市場需求逐漸恢復理性。值得注意的是,截至2025年6月30日止六個月的收入較2024年下半年增加人民幣2200萬元,反映收入的穩步增長與穩定狀況。

期內虧損從截至2024年6月30日止六個月的人民幣1.670億元減少人民幣9060萬元至截至2025年6月30日止六個月的人民幣7640萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account